Clinical Trial Update: Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 safety and pharmacokinetics evaluation of XOMA 052 in rheumatoid arthritis. The study is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• XOMA 052

Snippet

Sponsor: XOMA (US) LLC | Conditions: Rheumatoid Arthritis | Phase 2 | Status: SUSPENDED